In another study, authors used targeted silencing of two glycerophosphodiesterase genes, GDPD5 and GDPD6 by small interfering RNA (siRNA) for studying choline and phospholipid metabolism in MDA‐MB‐23 and MCF‐7 cell lines of breast cancer.109. The gene discussed is GDPD5; the disease is breast carcinoma.